Stockscreener 앱 받기
26.30
2.48%
0.6355
전일 마감가:
$25.67
열려 있는:
$26.3023
하루 거래량:
53
Relative Volume:
0.19
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.51%
1개월 성능:
+7.55%
6개월 성능:
+11.07%
1년 성능:
+6.78%
1일 변동 폭
$26.30
$26.30
1주일 범위
$25.42
$26.30
52주 변동 폭
$17.86
$28.74
Ishares Neuroscience And Healthcare Etf Stock (IBRN) Company Profile
명칭
Ishares Neuroscience And Healthcare Etf
전화
-
주소
-
IBRN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBRN
Ishares Neuroscience And Healthcare Etf
|
26.30 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
327.21 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
662.26 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
663.70 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.17 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
595.32 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Neuroscience And Healthcare Etf 주식(IBRN)의 최신 뉴스
Can You Invest in Neuralink? - Investing News Network
HeartSciences (NASDAQ:HSCS) Trading Up 10.9% – Still a Buy? - Defense World
VanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 37.5% in July - Defense World
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Alto Neuroscience (ANRO) Projected to Post Quarterly Earnings on Tuesday - Defense World
Hypercharge Networks (OTCMKTS:HCNWF) Trading 29.7% Higher – Should You Buy? - Defense World
Diversified Healthcare Trust (NASDAQ:DHCNL) Stock Price Down 0.3% – Time to Sell? - Defense World
Brighthouse Financial (NASDAQ:BHFAO) Shares Up 6.2% – Here’s Why - Defense World
Stifel Financial (NYSE:SF) Lowered to Sell Rating by Wall Street Zen - Defense World
Long Term Trading Analysis for (IBRN) - news.stocktradersdaily.com
(IBRN) Technical Data - news.stocktradersdaily.com
Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland - 富途牛牛
Learn to Evaluate (IBRN) using the Charts - news.stocktradersdaily.com
Healthcare Sector Slides As Hinge Health Shines Post-IPO - Finimize
Gauzy (GAUZ) vs. Its Competitors Head to Head Contrast - Defense World
Fidelity Emerging Markets (LON:FEML) Shares Down 1.1% – What’s Next? - Defense World
Do Wall Street Analysts Like Biogen Stock? - inkl
(IBRN) Trading Advice - news.stocktradersdaily.com
(IBRN) Proactive Strategies - news.stocktradersdaily.com
What Are Wall Street Analysts’ Target Price for Medtronic Stock? - inkl
(IBRN) Investment Analysis - news.stocktradersdaily.com
PositiveID (OTCMKTS:PSID) Stock Price Crosses Above 200 Day Moving Average – Should You Sell? - Defense World
Raymond James Financial Inc. Takes Position in First Trust Alerian Disruptive Technology Real Estate ETF (NYSEARCA:DTRE) - Defense World
Raymond James Financial Inc. Makes New $371,000 Investment in Synaptics Incorporated (NASDAQ:SYNA) - Defense World
Universal Music Group (OTCMKTS:UNVGY) Shares Up 3.7% – Still a Buy? - Defense World
(IBRN) Long Term Investment Analysis - news.stocktradersdaily.com
(IBRN) Trading Report - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Biogen Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Biogen Stock Outlook: Is Wall Street Bullish or Bearish? - TradingView
BlackRock, Inc. Expands Holdings in iShares Neuroscience and Hea - GuruFocus
Hone Your Biotech Allocation With Neuroscience ETF MNTL - ETF Trends
Top 5 Life Science ETFs in 2024 - Investing News Network
Future Health: Harnessing Innovations In Healthcare - Syfe
Medtronic Stock: Analyst Estimates & Ratings - TradingView
What Are Wall Street Analysts' Target Price For Lennar Stock? - Barchart.com
Is Wall Street Bullish Or Bearish On Biogen Stock? - Barchart.com
Where to Invest in Health Trends - Bloomberg.com
Neuralink Stock Price, Symbol: How to Invest in Neuralink IPO? - CoinCodex
Hot Investment Themes 2024: iShares Sets Sights on Harnessing Innovation and Opportunity - CCN.com
Three Investing Themes For 2024, From AI To Globalization - Finimize
How much thematic exposure do stock-market investors have? Here’s what BlackRock found. - MarketWatch
Best & Worst Sector ETFs of First-Half 2023 - Nasdaq
Finding Investment Opportunities In Neuroscience And AI - Seeking Alpha
Telling Humanity’s Brain Story: Insights From Brain Capital - Psychiatric Times
3 Themes Growth and Tech Investors May Want to Consider in 2023 - Nasdaq
BlackRock Singles Out Health Care as Its ‘Largest Overweight’ Position - Yahoo Finance
Best Performing ETFs for September 2022 - TheStreet
2 Innovative Stock Market Sectors to Invest in: BlackRock - Business Insider
Best Pharmaceutical ETFs - Investopedia
Momentum ETFs are overweight energy – an area where investors may fear getting their ‘butt kicked’ after big gains in 2022 - MarketWatch
Ishares Neuroscience And Healthcare Etf (IBRN) 재무 분석
Ishares Neuroscience And Healthcare Etf (IBRN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.35%
자본화:
|
볼륨(24시간):